This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Olon S.p.a.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Francesco Calogero: Innovator in Pharmaceutical Chemistry
Introduction
Francesco Calogero is a notable inventor based in Rodano, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on Olaparib, a drug used in cancer treatment. His expertise and dedication to research have led to the development of new forms of this important medication.
Latest Patents
Francesco Calogero holds a patent for "Crystalline and amorphous forms of Olaparib." This patent discloses a novel crystalline form and an amorphous form of Olaparib, along with the processes for their preparation. This innovation is crucial for enhancing the efficacy and stability of the drug.
Career Highlights
Calogero is associated with Olon S.p.A., a company known for its commitment to pharmaceutical development. His work at Olon has allowed him to focus on advancing drug formulations and improving therapeutic outcomes for patients.
Collaborations
Throughout his career, Francesco has collaborated with talented professionals, including Barbara Novo and Jacopo Bonanomi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Francesco Calogero's contributions to the field of pharmaceutical chemistry, particularly through his patent on Olaparib, highlight his role as an influential inventor. His work continues to impact the development of effective cancer treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile